October 2025 - Speedcell

BioSpain 2025, one of the most relevant biotechnology events in Europe, was held this year in Barcelona. HIPRA Biotech Services, the Contract Development and Manufacturing Organization (CDMO) of HIPRA, actively participated in this major event with its own stand, where it showcased its advanced solutions and services for the biotech industry.
The company took part in various activities within the framework of the congress. Among these, a highlight was the press conference dedicated to presenting the SPEEDCELL project to specialized industry media.

The session was led by Laura Ferrer, R&D Director for Human Health at HIPRA, and Eduard Viladesau, General Manager of HIPRA Biotech Services, who explained how SPEEDCELL is revolutionizing vaccine manufacturing.

The project, which aims to reduce vaccine production time to just 100 days, represents a significant leap forward in the automation and efficiency of biotechnological manufacturing processes. By integrating cutting-edge technologies and innovative production models, SPEEDCELL aspires to set a new standard in rapid vaccine development and contribute to global preparedness against emerging health threats.

HIPRA’s participation in BioSpain 2025 once again underscores its commitment to innovation, collaboration, and the advancement of biotechnology to improve health worldwide.

The Human Health Operations Executive Director of HIPRA, Jordi Ruano, attended the PDA – Parenteral Drug Association BioManufacturing Conference held in Rotterdam, where he had the opportunity to present the European project SPEEDCELL, led by HIPRA and funded by the EU4Health program.

During his presentation, Ruano not only introduced the core of the project but also emphasized its transformative ambition: to develop vaccines in just 100 days. This goal, which is aligned with the European Union’s priorities to enhance preparedness and response to health emergencies, represents a paradigm shift in the way future pandemics are addressed.

Ruano also shared concrete examples of how our R&D, Production, and Quality teams are working together to make this vision a reality.

His presentation sparked great interest among the PDA community, which highlighted the importance of projects like SPEEDCELL in strengthening Europe’s strategic autonomy and accelerating vaccine access in crisis situations.

Month: October 2025

HIPRA presents the SPEEDCELL project at BioSpain 2025

HIPRA presents the SPEEDCELL Project at the PDA BioManufacturing Conference